Cargando…
PMS2-associated Lynch syndrome: Past, present and future
Carriers of any pathogenic variant in one of the MMR genes (path_MMR carriers) were traditionally thought to be at comparable risk of developing a range of different malignancies, foremost colorectal cancer (CRC) and endometrial cancer. However, it is now widely accepted that their cancer risk and c...
Autores principales: | Andini, Katarina D., Nielsen, Maartje, Suerink, Manon, Helderman, Noah C., Koornstra, Jan Jacob, Ahadova, Aysel, Kloor, Matthias, Mourits, Marian J.E., Kok, Klaas, Sijmons, Rolf H., Bajwa–ten Broeke, Sanne W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989154/ https://www.ncbi.nlm.nih.gov/pubmed/36895471 http://dx.doi.org/10.3389/fonc.2023.1127329 |
Ejemplares similares
-
SNP association study in PMS2-associated Lynch syndrome
por: ten Broeke, Sanne W., et al.
Publicado: (2017) -
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
por: Sei, Shizuko, et al.
Publicado: (2023) -
Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers
por: Goverde, A., et al.
Publicado: (2017) -
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
por: Dominguez-Valentin, Mev, et al.
Publicado: (2019) -
Predictive functional assay‐based classification of PMS2 variants in Lynch syndrome
por: Rayner, Emily, et al.
Publicado: (2022)